Skip to content

Study · Observational study · n = 377 · 2019

1 result

Histrelin implantation in the pediatric population: A 10-year institutional experience.

Swendiman RA, Vogiatzi MG, Alter CA, Nance ML

Journal of pediatric surgery8 Sept 2018Cited by 12 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanObservational studySafety outcome

    In children undergoing histrelin implant procedures, complications occurred in 1% of cases.

    In plain wordsIn children, complications occurred in 1% of histrelin implant procedures.

    Peptide
    Histrelin
    Outcome
    Not applicableImplant procedure complications
    Study

    n = 377

    Outcome group
    Adverse events · Whole body
    Studied dose
    Dose not stated

    Measurements

    Complications
    1%
    cases

    Source sentences

    Summary
    Complications were rare (1% of cases).
    1 context sentence
    Summary · context
    A retrospective cohort study was performed including all patients (age ≤ 20) that underwent histrelin implant insertion, replacement, or removal by a single surgeon at a large pediatric tertiary care center (2008-2017).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.